Skip to main content
News Icon

News categories: Publication

Regulation of Innate Immune Responses by Platelets

Platelets have been extensively studied in the context of coagulation and their hemostatic imbalance can lead to conditions as atherosclerotic plaques and thrombosis. Nevertheless, the knowledge regarding the regulation of immune cell types by platelets has been growing exponentially in the past years. Among these biological systems, the innate immunity is remarkably affected by the crosstalk with platelets. This interaction comes from the formation of platelet-leukocyte aggregates, signaling by direct contact or by stimulation of immune cells by soluble factors and microparticles secreted by platelets. These blood components can sense and react danger signals, guiding leukocytes to injury sites and providing a scaffold for the formation of extracellular traps for microbial clearance. Using different mechanisms, platelets have the task to regulate the release of cytokines and chemokines upon sterile or infectious damage, modulate the expression of cell markers and control cell death and survival. Therefore, platelets are more than clotting agents, but critical players within the immune equilibrium for the host. Here we present an understanding about how platelets modulate innate immune cells, as well as a summary of the outcome of this interaction, an important step for therapeutic opportunities and future research on infectious and autoimmune diseases.


Publication

https://www.immunosensation.de/research/publications/pubmed/regulation-of-innate-immune-responses-by-platelets.html


Contact

Prof. Bernardo Franklin

Institute of Innate Immunity

Related news

Dr. Ivana Jorgacevic und Prof. Dr. Rayk Behrendt have discovered that the inflammatory messenger substance interferon-alpha can trigger Sjögren's syndrome: The researchers in Bonn.

News categories: Publication

New test points to precision treatment for autoimmune condition

Interferon alpha is an inflammatory mediator that can cause Sjögren’s syndrome, an autoimmune disease. This is revealed in a recent study carried out by the University Hospital Bonn together with the University of Bonn, the University of Edinburgh and Newcastle University. Their findings, which have been published in the journal “Lancet Rheumatology,” could make it easier in the medium term to develop drugs to fight this chronic condition.
View entry
Precise Konsortium

News categories: Publication Honors & Funding

Making Cancer Cells More Predictable: PRECISE Aims to Forecast Therapeutically Actionable Vulnerabilities

Which genes and signaling pathways does a cancer cell require to survive? And which of these could serve as therapeutic targets? The pan-European initiative PRECISE aims to identify such vulnerabilities not only through labor-intensive laboratory experiments but also by predicting them using computational models. The UKB and the University of Bonn, represented by Prof. Dr. Maximilian Billmann and Prof. Dr. Jonathan Schmid-Burgk, are among the founding partners of the consortium. The scientific vision of the initiative has now been published in a commentary in Nature Genetics.
View entry
Bild

News categories: Publication

Focus on the Guardians of the Antibody Response

For the immune system to effectively combat pathogens, antibody responses must be precisely controlled. So-called follicular regulatory T cells (Tfr cells) play a key role in this process by limiting excessive immune responses and helping to maintain immune tolerance. Researchers at the University Hospital Bonn (UKB) and the University of Bonn have now developed a robust laboratory method that allows Tfr cells to be generated from precursor cells and studied in a targeted manner. The results were recently published in the journal Cellular & Molecular Immunology.
View entry

Back to the news overview